The antimalarial drugs quinine, chloroquine and mefloquine are antagonists at 5‐HT3 receptors
Open Access
- 1 July 2007
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 151 (5), 666-677
- https://doi.org/10.1038/sj.bjp.0707238
Abstract
Background and Purpose: The antimalarial compounds quinine, chloroquine and mefloquine affect the electrophysiological properties of Cys‐loop receptors and have structural similarities to 5‐HT3 receptor antagonists. They may therefore act at 5‐HT3 receptors. Experimental Approach: The effects of quinine, chloroquine and mefloquine on electrophysiological and ligand binding properties of 5‐HT3A receptors expressed in HEK 293 cells and Xenopus oocytes were examined. The compounds were also docked into models of the binding site. Key Results: 5‐HT3 responses were blocked with IC50 values of 13.4 μM, 11.8 μM and 9.36 μM for quinine, chloroquine and mefloquine. Schild plots indicated quinine and chloroquine behaved competitively with pA2 values of 4.92 (KB=12.0 μM) and 4.97 (KB=16.4 μM). Mefloquine displayed weakly voltage‐dependent, non‐competitive inhibition consistent with channel block. On and off rates for quinine and chloroquine indicated a simple bimolecular reaction scheme. Quinine, chloroquine and mefloquine displaced [3H]granisetron with Ki values of 15.0, 24.2 and 35.7 μM. Docking of quinine into a homology model of the 5‐HT3 receptor binding site located the tertiary ammonium between W183 and Y234, and the quinoline ring towards the membrane, stabilised by a hydrogen bond with E129. For chloroquine, the quinoline ring was positioned between W183 and Y234 and the tertiary ammonium stabilised by interactions with F226. Conclusions and Implications: This study shows that quinine and chloroquine competitively inhibit 5‐HT3 receptors, while mefloquine inhibits predominantly non‐competitively. Both quinine and chloroquine can be docked into a receptor binding site model, consistent with their structural homology to 5‐HT3 receptor antagonists. British Journal of Pharmacology (2007) 151, 666–677; doi:10.1038/sj.bjp.0707238Keywords
This publication has 40 references indexed in Scilit:
- Defining the roles of Asn-128, Glu-129 and Phe-130 in loop A of the 5-HT3receptorMolecular Membrane Biology, 2006
- Effects of Quinine, Quinidine, and Chloroquine on α9α10 Nicotinic Cholinergic ReceptorsMolecular Pharmacology, 2005
- International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on Terms and Symbols in Quantitative PharmacologyPharmacological Reviews, 2003
- FUGUE: sequence-structure homology recognition using environment-specific substitution tables and structure-dependent gap penalties11Edited by B. HonigJournal of Molecular Biology, 2001
- Diltiazem causes open channel block of recombinant 5‐HT3 receptorsThe Journal of Physiology, 1999
- Analysis of competitive agonist-antagonist interactions by nonlinear regressionTrends in Pharmacological Sciences, 1995
- Ifenprodil inhibition of the 5-Hydroxytryptamine3 receptorNeuropharmacology, 1995
- Comparative Protein Modelling by Satisfaction of Spatial RestraintsJournal of Molecular Biology, 1993
- Adverse Effects of AntimalarialsDrug Safety, 1993
- MefloquineDrugs, 1993